Biopôle’s innovative life sciences community expands as Roche Pharma Switzerland joins as our latest corporate partner. The company is responsible for ensuring that patients in Switzerland have access to Roche’s innovative portfolio of medicines, working across oncology, rheumatology, pneumology, neurology, ophthalmology and rare diseases.
As the Swiss affiliate of a major global healthcare company, it seems almost inevitable that Roche Pharma Switzerland would feature among Biopôle’s corporate partners. The company is a highly welcome and valuable addition to our community. By joining the programme, Roche Pharma Switzerland will be able to participate in the innovative projects based on the Biopôle campus and beyond, as well as our industry knowledge and premium infrastructure.
The pharma expertise of Roche Pharma Switzerland is a tremendous asset to our members. Meanwhile, with this collaboration, Roche shows its openness and readiness to partner with innovative organisations in the French-speaking part of Switzerland.
Dr. med. Katharina Gasser, General Manager Roche Pharma Switzerland says, “The exciting and innovative atmosphere has been inspiring and I am excited about everything Biopôle has to offer. We will be able to collaborate and to learn from each other. Only together, with all our different skills, approaches and possibilities, can we make a difference.”
